跳至主要内容
临床试验/CTRI/2025/08/093433
CTRI/2025/08/093433尚未招募不适用

Building a healthier future: Artificial Intelligence-based early diagnosis of chronic kidney disease through retinal images

LifeBytes India Private Limited1 个研究点 分布在 1 个国家目标入组 3,384 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
3,384
试验地点
1
主要终点
serum creatinine and proteinuria

研究概览

简要总结

This study aims to optimize and validate an artificial intelligence (AI)-based model for the early diagnosis of chronic kidney disease (CKD) using retinal fundus images. A total of 3384 patients with CKD or diabetes or hypertension and control group will be enrolled at PGIMER, Chandigarh. Retinal images, clinical data, and blood/urine biomarkers will be collected, with blood samples also biobanked for future research. Data will be anonymized and analyzed by LifeBytes, Bengaluru, to develop and test the AI algorithm. The goal is to create a non-invasive, cost-effective, and scalable screening tool for early CKD detection, particularly suited for low-resource healthcare settings.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients with CKD (all stages), diabetes, or hypertension presenting at PGIMER, Chandigarh, will be recruited to identify retinal markers for early CKD diagnosis.

排除标准

  • Patients with a history of eye injury or prior eye surgery will be excluded.

结局指标

主要结局

serum creatinine and proteinuria

时间窗: baseline and three monthly till 2 years

次要结局

未报告次要终点

研究者

发起方
LifeBytes India Private Limited
申办方类型
Other [Bioinformatics consulting firm]
责任方
Principal Investigator
主要研究者

Smita Divyaveer

PGIMER Chandigarh

研究点 (1)

Loading locations...

相似试验